Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION) is a phase 3, randomised interventional study registered as NCT04928807 by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, with a registry enrolment figure of 231 participants, started 2021-07-20 and due to reach its primary completion in 2023-03-01. Interventions recorded: Short course radiotherapy sequential camrelizumab and chemotherapy. Conditions listed: Rectal Cancer. Primary outcome: pathological complete response (pCR) rate. Colorectal eligibility wording from the registry: "Histologically confirmed T3-44 and/or N+ rectal adenocarcinoma (AJCC/UICC TNM staging (8th Edition, 2017);". Sites: China. No results are recorded here; the registry entry is the source.